Centene (CNC) Stock Forecast & Price Target

$32.66 -0.60 (-1.80%)

Closing price 09/15/2025 03:59 PM Eastern

Extended Trading

$32.70 +0.04 (+0.12%)

As of 09/15/2025 07:58 PM Eastern

Compare

Centene - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Hold

Based on 17 Analyst Ratings

Sell
1

Hold
13

Buy
3

Based on 17 Wall Street analysts who have issued ratings for Centene in the last 12 months, the stock has a consensus rating of "Hold." Out of the 17 analysts, 1 has given a sell rating, 13 have given a hold rating, and 3 have given a buy rating for CNC.

Consensus Price Target

$38.33
17.37% Upside

According to the 17 analysts' twelve-month price targets for Centene, the average price target is $38.33. The highest price target for CNC is $73.00, while the lowest price target for CNC is $28.00. The average price target represents a forecasted upside of 17.37% from the current price of $32.66.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CNC and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Centene and its competitors.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CNC Analyst Ratings Over Time

Type	Current Forecast 9/16/24 to 9/16/25	1 Month Ago 8/17/24 to 8/17/25	3 Months Ago 6/18/24 to 6/18/25	1 Year Ago 9/17/23 to 9/16/24
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	9 Buy rating(s)	6 Buy rating(s)
Hold	13 Hold rating(s)	13 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$38.33	$42.20	$77.71	$85.58
Forecasted Upside	17.37% Upside	48.07% Upside	41.09% Upside	11.77% Upside
Consensus Rating	Hold	Hold	Moderate Buy	Hold

CNC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Centene Stock vs. The Competition

Type	Centene	Medical Companies	S&P 500
Consensus Rating Score	2.12	2.78	2.53
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	17.37% Upside	17,866.38% Upside	11.25% Upside
News Sentiment Rating	Positive News See Recent CNC News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
9/12/2025	Barclays 3 of 5 stars	Andrew Mok Not Rated	Boost Target	Equal Weight	$33.00 ➝ $35.00	+2.49%
9/12/2025	Truist Financial 3 of 5 stars	Ryan MacDonald Not Rated	Boost Target	Buy	$35.00 ➝ $39.00	+14.20%
9/5/2025	Sanford C. Bernstein 4 of 5 stars	Lance Wilkes Not Rated	Lower Target	Outperform	$40.00 ➝ $36.00	+25.68%
8/26/2025	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral	$38.00	+30.72%
8/4/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ricky Goldwasser Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$33.00 ➝ $28.00	+4.64%
7/29/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Stansel Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$48.00 ➝ $30.00	+13.79%
7/28/2025	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$45.00 ➝ $31.00	+15.37%
7/28/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$51.00 ➝ $43.00	+55.23%
7/25/2025	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$68.00 ➝ $28.00	+4.80%
7/23/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight	$72.00 ➝ $30.00	+7.72%
Get the Latest News and Ratings for CNC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.
7/21/2025	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Langston Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$73.00 ➝ $33.00	+18.07%
7/16/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kevin Fischbeck Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Neutral ➝ Underperform	$52.00 ➝ $30.00
7/11/2025	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Neutral	$71.00 ➝ $40.00	+26.10%
4/29/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Windley Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Hold	$64.00 ➝ $61.00	+2.98%
4/29/2025	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Cassorla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Neutral
2/6/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	J. Staszak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold
12/13/2024	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Equal Weight	$75.00 ➝ $73.00	+22.09%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Hold	$82.00 ➝ $87.00	+11.80%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:01 AM ET.

Should I Buy Centene Stock? CNC Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, September 11, 2025. Please send any questions or comments about these Centene pros and cons to contact@marketbeat.com.

Centene
Bull Case

Here are some ways that investors could benefit from investing in Centene Co.:

The current stock price is around $34.15, reflecting a recent increase of 9.2%, which may indicate positive market sentiment towards the company.
Centene Co. reported a significant revenue increase of 22.4% year-over-year, showcasing strong growth potential and operational efficiency.
The company has a market capitalization of approximately $16.77 billion, indicating a solid position in the healthcare sector, which can attract institutional investors.
Centene Co. has a relatively low P/E ratio of 8.45, suggesting that the stock may be undervalued compared to its earnings, potentially offering a good entry point for investors.
Recent insider purchases, including those by the CEO, demonstrate confidence in the company's future performance, which can be a positive signal for potential investors.

Centene
Bear Case

Investors should be bearish about investing in Centene Co. for these reasons:

The company reported a loss of ($0.16) earnings per share, missing analysts' expectations, which may raise concerns about its profitability in the short term.
Centene Co. has a relatively low net margin of 1.15%, indicating that it retains a small portion of its revenue as profit, which could limit growth opportunities.
The stock has experienced significant volatility, with a 1-year high of $77.29 and a low of $25.08, suggesting potential risks for investors looking for stability.
Insider ownership is only 0.36%, which may indicate a lack of alignment between management and shareholders, potentially affecting decision-making.
The company has a debt-to-equity ratio of 0.64, which, while manageable, indicates that it relies on debt financing, posing risks if market conditions change.

CNC Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Centene is $38.33, with a high forecast of $73.00 and a low forecast of $28.00.
: 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Centene in the last twelve months. There is currently 1 sell rating, 13 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNC, but not buy additional shares or sell existing shares.
: According to analysts, Centene's stock has a predicted upside of 17.37% based on their 12-month stock forecasts.
: Over the previous 90 days, Centene's stock had 4 downgrades by analysts.
: Centene has been rated by research analysts at Bank of America, Barclays, Cantor Fitzgerald, JPMorgan Chase & Co., Mizuho, Morgan Stanley, Oppenheimer, Robert W. Baird, Sanford C. Bernstein, TD Cowen, Truist Financial, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Centene less than other "medical" companies. The consensus rating for Centene is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CNC compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top-Rated Stocks

More Ratings Tools

This page (NYSE:CNC) was last updated on 9/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Centene (CNC) Stock Forecast & Price Target

Centene - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

CNC Analyst Ratings Over Time

CNC Analyst Recommendations By Month

CNC Price Targets by Month

Centene Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Centene Stock? CNC Pros and Cons Explained

Centene
Bull Case

Centene
Bear Case

CNC Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Centene (CNC) Stock Forecast & Price Target

Centene - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Consensus Price Target

CNC Analyst Ratings Over Time

CNC Analyst Recommendations By Month

CNC Price Targets by Month

Centene Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Centene Stock? CNC Pros and Cons Explained

Centene Bull Case

Centene Bear Case

CNC Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Centene
Bull Case

Centene
Bear Case